Clinical studies - Dry Eye

Author/s	Title / External Links
GENERAL
T. Shahraki, et al.	New advances in medical management of dry eye: optimizing treatment strategies for enhanced relief
M. Vidal-Rohr a, J.P. Craig b, L.N. Davies a, J.S. Wolffsohn	The epidemiology of dry eye disease in the UK: The Aston dry eye study
Che Arif, Fatin & Hilmi, Mohd Radzi & Kamal, Khairidzan & Ithnin, Mohd	Evaluation of 18 artificial tears based on viscosity and pH. Malaysian Journal of Ophthalmology
Yun-Jung Yang, Won-Young Lee, Young-jin Kim, Yeon-pyo Hong	A Meta-Analysis of the Efficacy of Hyaluronic Acid Eye Drops for the Treatment of Dry Eye Syndrome
M Moshirfar, W. B. West Jr. & D. P. Marx	Face Mask-Associated Ocular Irritation and Dryness
http://www.mims.co.uk	Ophthalmic Preparations, Preservatives and Potential Sensitisers as Ingredients Potential sensitising agents in eye drops and ointments.
The Ocular Surface Journal Jul-17 Volume 15, Issue 3, p269-650	TFOS International Dry Eye WorkShop (DEWS II)
C Baudouin, et al.	Revisiting the vicious circle of dry eye disease: a focus on the pathophysiology of meibomian gland dysfunction
The Ocular Surface Journal April 2007 Volume 5, Number 2	International Dry Eye Workshop (DEWS) 2007
Pasquale Aragona, Vincenzo Papa, Antonio Micali, Marcello Santocono, Giovanni Milazzo	Long term treatment with sodium hyaluronate-containing artificial tears reduces ocular surface damage in patients with dry eye
H Mochizuki, M Yamada, S Hato and T Nishida	Fluorophotometric measurement of the precorneal residence time of topically applied hyaluronic acid
Brignole F, Pisella PJ, Dupas B, Baeyens V, Baudoin C Graefes Arch Clin Exp Ophthalmol. 2005 Jun;243(6):531-8. Epub 2004 Dec 17	Efficacy and safety of 0.18% sodium hyaluronate in patients with moderate dry eye syndrome and superficial keratitis
Prabhasawat P, Tesavibul N, Kasetsuwan N. Br. J. Ophthalmol. 2007;91;47-50	Performance profile of sodium hyaluronate in patients with lipid tear deficiency: randomised, double-blind, controlled, exploratory study
REMOGEN® OMEGA
NEW: Kaercher T, et al.	Topical Omega-3 Polyunsaturated Fatty Acids for the Treatment of Dry Eye – Results from a Pilot Randomized Controlled Masked-Observer Study
Fevziye Ondes Yilmaz, et al.	Comparison of topical omega-3 fatty acids with topical sodium hyaluronate after corneal crosslinking : Short term results
Stefano Barabino, et al.	The role of systemic and topical fatty acids for dry eye treatment https://doi.org/10.1016/j.preteyeres.2017.05.003
VISMED®
NEW: Calonge et al.	Sodium hyaluronate 0.30% ocular gel versus sodium hyaluronate 0.18% eye drop in the treatment of moderate to severe dry eye disease
NEW: Emine Esra Karaca, Dilay Özek, Özlem Evren Kemer	Comparison study of two different topical lubricants on tear meniscus and tear osmolarity in dry eye
Szegedi S, et al.	Effect of Single Instillation of Two Hyaluronic Acid-Based Topical Lubricants on Tear Film Thickness in Patients with Dry Eye Syndrome
Baeyens V, Fiorentini R, Baudouin C, Dorsey F and The French VISMED® Study Group	Efficacy and safety of sodium hyaluronate 0.18% (VISMED®) vs sodium chloride 0.9% in patients with bilateral moderate dry eye (Need to register to access full free pdf file)
Ralph Pinheiro, Claudia Panfil, Norbert Schrage, Ralf Michael Dutescu	Comparison of the lubricant eyedrops Optive®, Vismed Multi®, and Cationorm® on the corneal healing process in an ex vivo model
Roger Vogel, R. Stephens Crockett, Neal Oden, Terry W. Laliberte, and Luis Molina, on behalf of the sodium hyaluronate ophthalmic solution study group	Demonstration of Efficacy in the Treatment of Dry Eye Disease with 0.18% Sodium Hyaluronate Ophthalmic Solution (Vismed, Rejena)
C.A. Kirby, and The Vismed Study Group. Invest. Ophthalmol. Vis. Sci. 2009; 50 : E-Abstract 4648-D892. Poster presented at the ARVO, Fort-Lauderdale, 3-7 May 2009	Superiority of Vismed® (Sodium Hyaluronate Ophthalmic Solution 0.18%) Compared with its Vehicle in the Treatment of the Signs and Symptoms of Dry Eye Disease
Baeyens V, Fiorentini R, Baudouin C, Dorsey F and The French VISMED® Study Group	Efficacy and safety of sodium hyaluronate 0.18% (VISMED®) vs sodium chloride 0.9% in patients with bilateral moderate dry eye
Zeher M, Bereczki Á, Sohajda Z, Márta J, Deák G, Ibnou-Zekri N, Baeyens V, poster presented at the 7th International Symposium on Ocular Pharmacology (ISOPT)-Budapest, Hungary, February 28- March 2, 2008	A 1-month study of efficacy and safety of 0.18% sodium hyaluronate (Vismed®) vs. 0.3% carbomer and 0.9% saline in patients with bilateral moderate dry eye syndrome
Johnson ME, Murphy PJ, Boulton M Graefes Arch Clin Exp Ophthalmol. 2006 Jan;244(1):109-12. Epub 2005 Jun 28.	Effectiveness of sodium hyaluronate eyedrops in the treatment of dry eye
Aleo D, Bossy L, poster presented at the 7th International Symposium on Ocular Pharmacology (ISOPT)-Budapest, Hungary, February 28- March 2, 2008	Considerations on the risk of precipitation of calcium phosphate salts following the use of VISMED® (0.18% sodium hyaluronate) formulation
Rapisarda A, Battaglia F, Bossy L, poster presented at the 7th International Symposium on Ocular Pharmacology (ISOPT)-Budapest, Hungary, February 28- March 2, 2008	Efficacy and safety of hypotonic 0.18% sodium hyaluronate solution (VISMED®) in patients with moderate dry eye - A study of the osmolarity of the tear film
Michael E. Johnson, Paul J. Murphy, Mike Boulton	Carbomer and Sodium Hyaluronate Eyedrops for Moderate Dry Eye Treatment
VISMED® GEL
NEW: Calonge et al.	Sodium hyaluronate 0.30% ocular gel versus sodium hyaluronate 0.18% eye drop in the treatment of moderate to severe dry eye disease
NEW: F A Che Arif, K Kamal, M R Hilmi, M H Ithnin	VISMED® GEL (Non-Preserved Sodium Hyaluronate eye drops) for the Treatment of Symptoms of Ocular Dryness and Discomfort in Patients with Sjögren's Syndrome
Clive Peckar	The Use of Sodium Hyaluronate Gel 0.3% in the Management of Post-Keratoplasty Patients, Chronic Refractory Dry Eye Patients and other Surface Proble ms
Clive Peckar Article in Eurotimes.	Sodium Hyaluronate Based Products. Management of post-LASIK dry eye and other dry eye problems.
Clive Peckar, et al Eurotimes Roundtable	Current Trends in the management of dry eye
LASERVIS
Dougherty P.J., Wellish K.L., Maloney R.K. (1994)	Excimer Laser Ablation Rate and Corneal Hydration. Am. J of Ophthalm. 118, 169-176
Arshinoff SA, Khoury E. J Cataract Refract Surg 1997; 23:1221-5.	HsS versus a balanced salt solution as a corneal wetting agent during routine cataract extraction and lens implantation
Alio J.L., Belda J.I., Shalaby A.: 2001;108:1246-1260 American Academy of Ophthalmology	Correction of Irregular Astigmatism with Excimer Laser Assisted by Sodium Hyaluronate
Vinciguerra P, Camesasca FI. J Refract Surg 2002; 18(3 Suppl):S371-3.	Butterfly laser epithelial keratomileusis for myopia
Lombardo M, Serrao S.(2004): Excimer Lasers. Journal of Refractive Surgery Vol 20 September/October 2004	Smoothing of the ablated porcine anterior corneal surface using Technolas Keratocor 217C and Nidek EC-5000
Vinciguerra P., Camesasca FI, Torres IM Journal of Refractive Surgery Volume 20 September/October (Suppl) 2004	One-year results of custom laser epithalial keratomileusis with the Nidek system
J Cataract Refract Surg 2005;31:39-47 ASCRS & ESCRS Vinciguerra P., Camesasca F.I., Torres Munoz M.I. (2005):	Transition zone design and smoothing in custom laser-assisted subepithelial keratectomy
Vinciguerra P, Munoz MI, Camesasca FI, Grizzi F, Roberts C. J Cataract Refract Surg. 2005 Jan;31(1):82-7.	Long-term follow-up of ultrathin corneas after surface retreatment with phototherapeutickeratectomy.
Lombardo M, De Santo MP, Barberi R, Serrao S. J Refract Surg. 2005 Sep-Oct;21(5):469-75	Roughness of excimer laser ablated corneas with and without smoothing measured with atomic force microscopy
VISIOL ®
Belda JI, Artola A, Garcia-Manzanares MD, Ferrer C, Haroun HE, Hassanein A, Baeyens V, Munoz G, Aliò JL J Cataract Refract Surg 2005; 31:1213-1218 © 2005 ASCRS and ESCRS	Hyaluronic acid combined with mannitol to improve protection against free-radical endothelial damage: Experimental Model
Miranda M, Bosch-Morell F, Belda JI, García-Manzanares MD, Barcia J, Alió JL, Romero FJ Ophthalmic Res. 2007;39(5):260-4. Epub 2007 Sep 12.	Protective Effect of Viscoelastics against Retina Lipid Peroxidation
Peckar C, study results presented at the 24th congress of the Asia-Pacific Academy of Ophthalmology (APAO)-Bali, Indonesia, May 17th, 2009	New OVDs: Does 2% Sodium Hyaluronate (VISIOL®) have significant advantages over 1% Sodium Hyaluronate to justify its use in Routine Cataract Phacoemulsification?

For other studies not shown on this list please contact TRB Chemedica (UK) Ltd:

TRB Chemedica (UK) Ltd
9 Evolution
Lymedale Business Park
Hooters Hall Road
Newcastle-under-Lyme
ST5 9QF

Tel: 01782 563207
Email: info@trbchemedica.co.uk